NOVO HOLDINGS A/S sold 0.3% of their position (13.30K shares) of CYTEIR THERAPEUTICS, INC. on the open market
Open‑market sale worth $25.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/23/2023ACC: 0001209191-23-039545
10% Owner
Since Jun 2021
-13.30K
Net shares
Net seller
$25.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
13.30K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.83K
Price / share
$1.99
Trade value
$9.64K
% of position
0.1%
6/21/2023
3.92M→3.91M
Common Stock
Direct
Shares
−5.04K
Price / share
$1.94
Trade value
$9.78K
% of position
0.1%
6/22/2023
3.91M→3.91M
Common Stock
Direct
Shares
−3.42K
Price / share
$1.88
Trade value
$6.45K
% of position
0.1%
6/23/2023
3.91M→3.90M
Total
Net shares
−13.30K
Net value
-$25.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2023 | S · Sale | −4.83K | $1.99 | $9.64K | 0.1% | 3.92M | 3.91M |
| Common Stock Direct | 6/22/2023 | S · Sale | −5.04K | $1.94 | $9.78K | 0.1% | 3.91M | 3.91M |
| Common Stock Direct | 6/23/2023 | S · Sale | −3.42K | $1.88 | $6.45K | 0.1% | 3.91M | 3.90M |
| Total | −13.30K | -$25.87K | ||||||
Derivative Transactions0
No derivative transactions reported